France· FR:64381382
DULOXETINE ACCORD 60 mg, gélule gastro-résistante
A medicinal product containing chlorhydrate de duloxétine, registered in France by ACCORD HEALTHCARE FRANCE, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- CHLORHYDRATE DE DULOXÉTINE
- Manufacturer
- ACCORD HEALTHCARE FRANCE
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip13340093004244128 plaquettes prédécoupées unitaires aluminium de 1 compriméEUR 4.36
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Chlorhydrate de duloxétine in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesCymbaltaEli Lilly and Company
- SpainCYMBALTA 60 MG CAPSULAS DURAS GASTRORRESISTENTESEli Lilly Nederland B.V.
- United KingdomCymbalta 60mg gastro-resistant capsulesDE Pharmaceuticals
- ItalyALIKRESLABORATORIO FARMACEUTICO C.T. S.R.L.
- CanadaACCEL-DULOXETINEACCEL PHARMA INC
- PolandAuroDuloxAurovitas Pharma Polska Sp. z o.o.
- NetherlandsCymbalta 60 mg, maagsapresistente capsules, hardEli Lilly Nederland BV
- SwedenAritavi 60 mg Enterokapsel, hårdTeva B.V.
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Dulasolan, Duloxetin +pharma
- Belgium · Duloxetin Ab, Duloxétine Ab
- Bulgaria · Dulasolan, Duxet
- Cyprus · Dulox, Duloxetine Accord
- Czechia · Dolyxan, Dulasolan
- Germany · Dulasolan, Duloxalta
- Denmark · Aritavi, Duciltia
- Estonia · Dulsevia, Onelar
- Spain · Dedulox 30 Mg Cápsulas Duras Gastrorresistentes Efg, Dedulox 60 Mg
- Finland · Duloxetin Stada, Duloxetine Accord
- United Kingdom (Northern Ireland) · Depalta, Duciltia
- Greece · Duciltia, Duloxetine Liconsa
- Croatia · Dolyxan, Duloksetin Pliva
- Hungary · Duciltia, Dulodet
- Ireland · Duloxetine Accord, Duloxetine Clonmel
- Iceland · Aritavi, Cymbalta
- Italy · Alikres, Dulex
- Liechtenstein · Cymbalta, Duloxetine Lilly
- Lithuania · Dulsevia
- Luxembourg · Duloxetin Ab, Duloxetine Liconsa
- Latvia · Dulsevia
- Malta · Onelar
- Netherlands · Dulasolan, Dulodet
- Norway · Cymbalta, Duloxetin Krka
- Poland · Aurodulox, Depratal
- Portugal · Duloxetina Alter, Duloxetina Amperlem
- Romania · Dozzex, Duloxetină Dr. Reddy's
- Sweden · Aritavi, Dulmis
- Slovenia · Duloksetin Sandoz, Dulsevia
- Slovakia · Duloxetin Krka, Duloxetin Krka, D.D., Novo Mesto
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fe0b8e0b-4597-4193-82aa-fa09ca42c6dc GET /v1/drugs/fe0b8e0b-4597-4193-82aa-fa09ca42c6dc?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "64381382",
"date_amm": "2018-05-18",
"type_amm": "Procédure décentralisée",
"numero_ue": null,
"substance": "CHLORHYDRATE DE DULOXÉTINE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "gélule gastro-résistant(e)",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about chlorhydrate de duloxétine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.